AIMC Topic: Mycoplasma pneumoniae

Clear Filters Showing 11 to 14 of 14 articles

Predicting and interpreting key features of refractory Mycoplasma pneumoniae pneumonia using multiple machine learning methods.

Scientific reports
In recent years, the incidence of refractory Mycoplasma pneumoniae pneumonia (RMPP) has significantly risen, posing severe pulmonary and extrapulmonary complications, making early identification a challenge for clinicians. In this retrospective singl...

Metabolomics and machine learning identify urine metabolic characteristics and potential biomarkers for severe Mycoplasma pneumoniae pneumonia.

Scientific reports
To study the differences in the urine metabolome between pediatric patients with severe Mycoplasma pneumoniae pneumonia (SMPP) and those with general Mycoplasma pneumoniae pneumonia (GMPP) via non-targeted metabolomics method, and potential biomarker...

Development and validation of an early diagnosis model for severe mycoplasma pneumonia in children based on interpretable machine learning.

Respiratory research
BACKGROUND: Pneumonia is a major threat to the health of children, especially those under the age of five. Mycoplasma  pneumoniae infection is a core cause of pediatric pneumonia, and the incidence of severe mycoplasma pneumoniae pneumonia (SMPP) has...